Stock Taper 
PROPEL BIO MANAGEMENT, LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Corvus Pharmaceuticals, Inc. | CRVS | 70.38K | $1.05M |
 Celldex Therapeutics, Inc. | CLDX | 103.69K | $3.86M |
 Corcept Therapeutics Incorporated | CORT | 136.5K | $11.87M |
 EyePoint Pharmaceuticals, Inc. | EYPT | 191.75K | $2.74M |
 4D Molecular Therapeutics, Inc. | FDMT | 252.65K | $3.36M |
 Zevra Therapeutics, Inc. | ZVRA | 253.54K | $3.64M |
 Immunic, Inc. | IMUX | 325.02K | $5M |
 Ocular Therapeutix, Inc. | OCUL | 357.97K | $3.52M |
 SCYNEXIS, Inc. | SCYX | 543.48K | $2.21M |
 COMPASS Pathways plc | CMPS | 573.09K | $8.11M |
 Delcath Systems, Inc. | DCTH | 871.46K | $10.97M |
 Phathom Pharmaceuticals, Inc. | PHAT | 1.05M | $11.4M |
 Plains GP Holdings LP | PAGP | 1.27M | $30.88M |
 Aquestive Therapeutics, Inc. | AQST | 1.44M | $6M |